Resources with keywords: shipping
This guidance applies to Filoviruses, Arenaviruses, Rift Valley fever virus, Crimean Congo HFV. This guidance also applies to other high-consequence diseases that require a specialized laboratory, are highly pathogenic, and have no vaccine or treatment currently available, like Nipah virus disease.
The CDC is reporting a recently confirmed outbreak of Ebola virus disease (EVD) in Uganda caused by Sudan virus (species Sudan ebolavirus) to summarize CDC’s recommendations for U.S. public health departments and clinicians, case identification and testing, and clinical laboratory biosafety considerations.
This webpage provides guidance for staff at hospitals and clinical laboratories on collecting, transporting, and submitting specimens to laboratories to test for viral hemorrhagic fevers (VHFs) or other high-consequence diseases.
Routine laboratory testing to monitor the patient’s clinical status and diagnostic testing for other potential causes of the patient’s illness should be pursued while testing for a VHF or other high-consequence disease is underway.
This document includes Monkeypox in the EXAMPLE OF CATEGORY A: UN2814, INFECTIOUS SUBSTANCES AFFECTING HUMANS
Quick reference guide adapted from the CDC Laboratory Training course for shipping Covid samples.
APHL’s Sentinel Laboratory Partnerships and Outreach Subcommittee of the Public Health Preparedness and Response
Committee developed this Packaging and Shipping Evaluation Tool to provide a standardized resource for public health
laboratories (PHLs) to assess shipments received in the laboratory.
Welch SR. et al.
This site includes updated information on importing SARS-CoV-2 isolates, cultures or fluids reasonably expected to contain SARS-CoV-2.
Includes a FAQs on import permits in the US, including questions about SARS-CoV-2
